Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 9.87% | 9.45% | 10.39% | 1.64% | -0.32% |
| Total Other Revenue | 4.00% | 4.17% | -8.70% | -18.52% | 19.05% |
| Total Revenue | 9.80% | 9.38% | 10.17% | 1.36% | -0.14% |
| Cost of Revenue | 8.13% | 6.68% | 12.48% | 5.63% | 4.15% |
| Gross Profit | 10.51% | 10.47% | 9.21% | -0.37% | -1.85% |
| SG&A Expenses | 16.16% | 8.17% | 5.18% | 20.23% | 2.66% |
| Depreciation & Amortization | -9.90% | -12.76% | -10.93% | -11.94% | -2.19% |
| Other Operating Expenses | -100.00% | -- | 200.00% | -- | -- |
| Total Operating Expenses | 7.71% | 4.56% | 6.25% | 8.26% | 3.70% |
| Operating Income | 18.46% | 30.69% | 33.22% | -31.63% | -13.36% |
| Income Before Tax | 98.04% | -174.26% | 161.24% | -65.85% | -1,800.00% |
| Income Tax Expenses | -24.53% | 55.56% | 420.00% | 556.25% | 203.92% |
| Earnings from Continuing Operations | 88.54% | -194.79% | 119.42% | -216.67% | -669.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 200.00% | 83.33% | 366.67% | 100.00% |
| Net Income | 90.49% | -194.74% | 117.93% | -191.30% | -694.20% |
| EBIT | 18.46% | 30.69% | 33.22% | -31.63% | -13.36% |
| EBITDA | 6.09% | 11.50% | 9.95% | -20.18% | -8.05% |
| EPS Basic | 90.27% | -193.99% | 117.81% | -189.38% | -689.46% |
| Normalized Basic EPS | 33.32% | 4,750.85% | 136.38% | -77.79% | -20.31% |
| EPS Diluted | 90.28% | -194.05% | 117.49% | -189.38% | -690.14% |
| Normalized Diluted EPS | 33.32% | 4,831.03% | 136.16% | -77.79% | -19.41% |
| Average Basic Shares Outstanding | -2.28% | 0.80% | 0.72% | 0.69% | 0.79% |
| Average Diluted Shares Outstanding | -2.28% | 0.55% | 1.35% | 0.69% | -0.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
